Oncolytic Virus Therapy Market - Global Outlook and Forecast 2021-2027

January 2021 | 101 pages | ID: O75E45561807EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Oncolytic Virus Therapy in Global, including the following market information:
Global Oncolytic Virus Therapy Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Oncolytic Virus Therapy market was valued at 5 million in 2020 and is projected to reach US$ 12 million by 2027, at a CAGR of 23.8% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Oncolytic Virus Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Oncolytic Virus Therapy Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Oncolytic Virus Therapy Market Segment Percentages, By Type, 2020 (%)

• HSV-based Oncolytic Viruses
• Adenoviruses-based Oncolytic Viruses
• Vaccinia Virus-based Oncolytic Viruses
• Vesicular Stomatitis Virus-based Oncolytic Viruses
• Newcastle Disease Virus-based Oncolytic Viruses

China Oncolytic Virus Therapy Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Oncolytic Virus Therapy Market Segment Percentages, By Application, 2020 (%)

• Melanoma
• Prostate Cancer
• Breast Cancer
• Ovarian Cancer
• Others

Global Oncolytic Virus Therapy Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Oncolytic Virus Therapy Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Oncolytic Virus Therapy Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Oncolytic Virus Therapy Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• Amgen
• Oncolytics Biotech
• Viralytics
• Transgene SA
• Oncolys BioPharma
• Targovax
• PsiOxus Therapeutics
• SillaJen Biotherapeutics
• Sorrento Therapeutics
• Lokon Pharma
• Genelux Corporation
• Vyriad
• TILT Biotherapeutics
• Cold Genesys

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Oncolytic Virus Therapy Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Oncolytic Virus Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ONCOLYTIC VIRUS THERAPY OVERALL MARKET SIZE

2.1 Global Oncolytic Virus Therapy Market Size: 2021 VS 2027
2.2 Global Oncolytic Virus Therapy Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Oncolytic Virus Therapy Players in Global Market
3.2 Top Global Oncolytic Virus Therapy Companies Ranked by Revenue
3.3 Global Oncolytic Virus Therapy Revenue by Companies
3.4 Top 3 and Top 5 Oncolytic Virus Therapy Companies in Global Market, by Revenue in 2020
3.5 Global Companies Oncolytic Virus Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Oncolytic Virus Therapy Players in Global Market
  3.6.1 List of Global Tier 1 Oncolytic Virus Therapy Companies
  3.6.2 List of Global Tier 2 and Tier 3 Oncolytic Virus Therapy Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Oncolytic Virus Therapy Market Size Markets, 2021 & 2027
  4.1.2 HSV-based Oncolytic Viruses
  4.1.3 Adenoviruses-based Oncolytic Viruses
  4.1.4 Vaccinia Virus-based Oncolytic Viruses
  4.1.5 Vesicular Stomatitis Virus-based Oncolytic Viruses
  4.1.6 Newcastle Disease Virus-based Oncolytic Viruses
4.2 By Type - Global Oncolytic Virus Therapy Revenue & Forecasts
  4.2.1 By Type - Global Oncolytic Virus Therapy Revenue, 2016-2021
  4.2.2 By Type - Global Oncolytic Virus Therapy Revenue, 2022-2027
  4.2.3 By Type - Global Oncolytic Virus Therapy Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Oncolytic Virus Therapy Market Size, 2021 & 2027
  5.1.2 Melanoma
  5.1.3 Prostate Cancer
  5.1.4 Breast Cancer
  5.1.5 Ovarian Cancer
  5.1.6 Others
5.2 By Application - Global Oncolytic Virus Therapy Revenue & Forecasts
  5.2.1 By Application - Global Oncolytic Virus Therapy Revenue, 2016-2021
  5.2.2 By Application - Global Oncolytic Virus Therapy Revenue, 2022-2027
  5.2.3 By Application - Global Oncolytic Virus Therapy Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Oncolytic Virus Therapy Market Size, 2021 & 2027
6.2 By Region - Global Oncolytic Virus Therapy Revenue & Forecasts
  6.2.1 By Region - Global Oncolytic Virus Therapy Revenue, 2016-2021
  6.2.2 By Region - Global Oncolytic Virus Therapy Revenue, 2022-2027
  6.2.3 By Region - Global Oncolytic Virus Therapy Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Oncolytic Virus Therapy Revenue, 2016-2027
  6.3.2 US Oncolytic Virus Therapy Market Size, 2016-2027
  6.3.3 Canada Oncolytic Virus Therapy Market Size, 2016-2027
  6.3.4 Mexico Oncolytic Virus Therapy Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Oncolytic Virus Therapy Revenue, 2016-2027
  6.4.2 Germany Oncolytic Virus Therapy Market Size, 2016-2027
  6.4.3 France Oncolytic Virus Therapy Market Size, 2016-2027
  6.4.4 U.K. Oncolytic Virus Therapy Market Size, 2016-2027
  6.4.5 Italy Oncolytic Virus Therapy Market Size, 2016-2027
  6.4.6 Russia Oncolytic Virus Therapy Market Size, 2016-2027
  6.4.7 Nordic Countries Oncolytic Virus Therapy Market Size, 2016-2027
  6.4.8 Benelux Oncolytic Virus Therapy Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Oncolytic Virus Therapy Revenue, 2016-2027
  6.5.2 China Oncolytic Virus Therapy Market Size, 2016-2027
  6.5.3 Japan Oncolytic Virus Therapy Market Size, 2016-2027
  6.5.4 South Korea Oncolytic Virus Therapy Market Size, 2016-2027
  6.5.5 Southeast Asia Oncolytic Virus Therapy Market Size, 2016-2027
  6.5.6 India Oncolytic Virus Therapy Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Oncolytic Virus Therapy Revenue, 2016-2027
  6.6.2 Brazil Oncolytic Virus Therapy Market Size, 2016-2027
  6.6.3 Argentina Oncolytic Virus Therapy Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Oncolytic Virus Therapy Revenue, 2016-2027
  6.7.2 Turkey Oncolytic Virus Therapy Market Size, 2016-2027
  6.7.3 Israel Oncolytic Virus Therapy Market Size, 2016-2027
  6.7.4 Saudi Arabia Oncolytic Virus Therapy Market Size, 2016-2027
  6.7.5 UAE Oncolytic Virus Therapy Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Amgen
  7.1.1 Amgen Corporate Summary
  7.1.2 Amgen Business Overview
  7.1.3 Amgen Oncolytic Virus Therapy Major Product Offerings
  7.1.4 Amgen Oncolytic Virus Therapy Revenue in Global (2016-2021)
  7.1.5 Amgen Key News
7.2 Oncolytics Biotech
  7.2.1 Oncolytics Biotech Corporate Summary
  7.2.2 Oncolytics Biotech Business Overview
  7.2.3 Oncolytics Biotech Oncolytic Virus Therapy Major Product Offerings
  7.2.4 Oncolytics Biotech Oncolytic Virus Therapy Revenue in Global (2016-2021)
  7.2.5 Oncolytics Biotech Key News
7.3 Viralytics
  7.3.1 Viralytics Corporate Summary
  7.3.2 Viralytics Business Overview
  7.3.3 Viralytics Oncolytic Virus Therapy Major Product Offerings
  7.3.4 Viralytics Oncolytic Virus Therapy Revenue in Global (2016-2021)
  7.3.5 Viralytics Key News
7.4 Transgene SA
  7.4.1 Transgene SA Corporate Summary
  7.4.2 Transgene SA Business Overview
  7.4.3 Transgene SA Oncolytic Virus Therapy Major Product Offerings
  7.4.4 Transgene SA Oncolytic Virus Therapy Revenue in Global (2016-2021)
  7.4.5 Transgene SA Key News
7.5 Oncolys BioPharma
  7.5.1 Oncolys BioPharma Corporate Summary
  7.5.2 Oncolys BioPharma Business Overview
  7.5.3 Oncolys BioPharma Oncolytic Virus Therapy Major Product Offerings
  7.5.4 Oncolys BioPharma Oncolytic Virus Therapy Revenue in Global (2016-2021)
  7.5.5 Oncolys BioPharma Key News
7.6 Targovax
  7.6.1 Targovax Corporate Summary
  7.6.2 Targovax Business Overview
  7.6.3 Targovax Oncolytic Virus Therapy Major Product Offerings
  7.6.4 Targovax Oncolytic Virus Therapy Revenue in Global (2016-2021)
  7.6.5 Targovax Key News
7.7 PsiOxus Therapeutics
  7.7.1 PsiOxus Therapeutics Corporate Summary
  7.7.2 PsiOxus Therapeutics Business Overview
  7.7.3 PsiOxus Therapeutics Oncolytic Virus Therapy Major Product Offerings
  7.4.4 PsiOxus Therapeutics Oncolytic Virus Therapy Revenue in Global (2016-2021)
  7.7.5 PsiOxus Therapeutics Key News
7.8 SillaJen Biotherapeutics
  7.8.1 SillaJen Biotherapeutics Corporate Summary
  7.8.2 SillaJen Biotherapeutics Business Overview
  7.8.3 SillaJen Biotherapeutics Oncolytic Virus Therapy Major Product Offerings
  7.8.4 SillaJen Biotherapeutics Oncolytic Virus Therapy Revenue in Global (2016-2021)
  7.8.5 SillaJen Biotherapeutics Key News
7.9 Sorrento Therapeutics
  7.9.1 Sorrento Therapeutics Corporate Summary
  7.9.2 Sorrento Therapeutics Business Overview
  7.9.3 Sorrento Therapeutics Oncolytic Virus Therapy Major Product Offerings
  7.9.4 Sorrento Therapeutics Oncolytic Virus Therapy Revenue in Global (2016-2021)
  7.9.5 Sorrento Therapeutics Key News
7.10 Lokon Pharma
  7.10.1 Lokon Pharma Corporate Summary
  7.10.2 Lokon Pharma Business Overview
  7.10.3 Lokon Pharma Oncolytic Virus Therapy Major Product Offerings
  7.10.4 Lokon Pharma Oncolytic Virus Therapy Revenue in Global (2016-2021)
  7.10.5 Lokon Pharma Key News
7.11 Genelux Corporation
  7.11.1 Genelux Corporation Corporate Summary
  7.11.2 Genelux Corporation Business Overview
  7.11.3 Genelux Corporation Oncolytic Virus Therapy Major Product Offerings
  7.11.4 Genelux Corporation Oncolytic Virus Therapy Revenue in Global (2016-2021)
  7.11.5 Genelux Corporation Key News
7.12 Vyriad
  7.12.1 Vyriad Corporate Summary
  7.12.2 Vyriad Business Overview
  7.12.3 Vyriad Oncolytic Virus Therapy Major Product Offerings
  7.12.4 Vyriad Oncolytic Virus Therapy Revenue in Global (2016-2021)
  7.12.5 Vyriad Key News
7.13 TILT Biotherapeutics
  7.13.1 TILT Biotherapeutics Corporate Summary
  7.13.2 TILT Biotherapeutics Business Overview
  7.13.3 TILT Biotherapeutics Oncolytic Virus Therapy Major Product Offerings
  7.13.4 TILT Biotherapeutics Oncolytic Virus Therapy Revenue in Global (2016-2021)
  7.13.5 TILT Biotherapeutics Key News
7.14 Cold Genesys
  7.14.1 Cold Genesys Corporate Summary
  7.14.2 Cold Genesys Business Overview
  7.14.3 Cold Genesys Oncolytic Virus Therapy Major Product Offerings
  7.14.4 Cold Genesys Oncolytic Virus Therapy Revenue in Global (2016-2021)
  7.14.5 Cold Genesys Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Oncolytic Virus Therapy Market Opportunities & Trends in Global Market
Table 2. Oncolytic Virus Therapy Market Drivers in Global Market
Table 3. Oncolytic Virus Therapy Market Restraints in Global Market
Table 4. Key Players of Oncolytic Virus Therapy in Global Market
Table 5. Top Oncolytic Virus Therapy Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Oncolytic Virus Therapy Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Oncolytic Virus Therapy Revenue Share by Companies, 2016-2021
Table 8. Global Companies Oncolytic Virus Therapy Product Type
Table 9. List of Global Tier 1 Oncolytic Virus Therapy Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Oncolytic Virus Therapy Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Oncolytic Virus Therapy Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Oncolytic Virus Therapy Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Oncolytic Virus Therapy Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Oncolytic Virus Therapy Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Oncolytic Virus Therapy Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Oncolytic Virus Therapy Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Oncolytic Virus Therapy Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Oncolytic Virus Therapy Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Oncolytic Virus Therapy Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Oncolytic Virus Therapy Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Oncolytic Virus Therapy Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Oncolytic Virus Therapy Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Oncolytic Virus Therapy Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Oncolytic Virus Therapy Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Oncolytic Virus Therapy Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Oncolytic Virus Therapy Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Oncolytic Virus Therapy Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Oncolytic Virus Therapy Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Oncolytic Virus Therapy Revenue, (US$, Mn), 2022-2027
Table 30. Amgen Corporate Summary
Table 31. Amgen Oncolytic Virus Therapy Product Offerings
Table 32. Amgen Oncolytic Virus Therapy Revenue (US$, Mn), (2016-2021)
Table 33. Oncolytics Biotech Corporate Summary
Table 34. Oncolytics Biotech Oncolytic Virus Therapy Product Offerings
Table 35. Oncolytics Biotech Oncolytic Virus Therapy Revenue (US$, Mn), (2016-2021)
Table 36. Viralytics Corporate Summary
Table 37. Viralytics Oncolytic Virus Therapy Product Offerings
Table 38. Viralytics Oncolytic Virus Therapy Revenue (US$, Mn), (2016-2021)
Table 39. Transgene SA Corporate Summary
Table 40. Transgene SA Oncolytic Virus Therapy Product Offerings
Table 41. Transgene SA Oncolytic Virus Therapy Revenue (US$, Mn), (2016-2021)
Table 42. Oncolys BioPharma Corporate Summary
Table 43. Oncolys BioPharma Oncolytic Virus Therapy Product Offerings
Table 44. Oncolys BioPharma Oncolytic Virus Therapy Revenue (US$, Mn), (2016-2021)
Table 45. Targovax Corporate Summary
Table 46. Targovax Oncolytic Virus Therapy Product Offerings
Table 47. Targovax Oncolytic Virus Therapy Revenue (US$, Mn), (2016-2021)
Table 48. PsiOxus Therapeutics Corporate Summary
Table 49. PsiOxus Therapeutics Oncolytic Virus Therapy Product Offerings
Table 50. PsiOxus Therapeutics Oncolytic Virus Therapy Revenue (US$, Mn), (2016-2021)
Table 51. SillaJen Biotherapeutics Corporate Summary
Table 52. SillaJen Biotherapeutics Oncolytic Virus Therapy Product Offerings
Table 53. SillaJen Biotherapeutics Oncolytic Virus Therapy Revenue (US$, Mn), (2016-2021)
Table 54. Sorrento Therapeutics Corporate Summary
Table 55. Sorrento Therapeutics Oncolytic Virus Therapy Product Offerings
Table 56. Sorrento Therapeutics Oncolytic Virus Therapy Revenue (US$, Mn), (2016-2021)
Table 57. Lokon Pharma Corporate Summary
Table 58. Lokon Pharma Oncolytic Virus Therapy Product Offerings
Table 59. Lokon Pharma Oncolytic Virus Therapy Revenue (US$, Mn), (2016-2021)
Table 60. Genelux Corporation Corporate Summary
Table 61. Genelux Corporation Oncolytic Virus Therapy Product Offerings
Table 62. Genelux Corporation Oncolytic Virus Therapy Revenue (US$, Mn), (2016-2021)
Table 63. Vyriad Corporate Summary
Table 64. Vyriad Oncolytic Virus Therapy Product Offerings
Table 65. Vyriad Oncolytic Virus Therapy Revenue (US$, Mn), (2016-2021)
Table 66. TILT Biotherapeutics Corporate Summary
Table 67. TILT Biotherapeutics Oncolytic Virus Therapy Product Offerings
Table 68. TILT Biotherapeutics Oncolytic Virus Therapy Revenue (US$, Mn), (2016-2021)
Table 69. Cold Genesys Corporate Summary
Table 70. Cold Genesys Oncolytic Virus Therapy Product Offerings
Table 71. Cold Genesys Oncolytic Virus Therapy Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Oncolytic Virus Therapy Segment by Type
Figure 2. Oncolytic Virus Therapy Segment by Application
Figure 3. Global Oncolytic Virus Therapy Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Oncolytic Virus Therapy Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Oncolytic Virus Therapy Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Oncolytic Virus Therapy Revenue in 2020
Figure 8. By Type - Global Oncolytic Virus Therapy Revenue Market Share, 2016-2027
Figure 9. By Application - Global Oncolytic Virus Therapy Revenue Market Share, 2016-2027
Figure 10. By Region - Global Oncolytic Virus Therapy Revenue Market Share, 2016-2027
Figure 11. By Country - North America Oncolytic Virus Therapy Revenue Market Share, 2016-2027
Figure 12. US Oncolytic Virus Therapy Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Oncolytic Virus Therapy Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Oncolytic Virus Therapy Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Oncolytic Virus Therapy Revenue Market Share, 2016-2027
Figure 16. Germany Oncolytic Virus Therapy Revenue, (US$, Mn), 2016-2027
Figure 17. France Oncolytic Virus Therapy Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Oncolytic Virus Therapy Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Oncolytic Virus Therapy Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Oncolytic Virus Therapy Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Oncolytic Virus Therapy Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Oncolytic Virus Therapy Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Oncolytic Virus Therapy Revenue Market Share, 2016-2027
Figure 24. China Oncolytic Virus Therapy Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Oncolytic Virus Therapy Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Oncolytic Virus Therapy Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Oncolytic Virus Therapy Revenue, (US$, Mn), 2016-2027
Figure 28. India Oncolytic Virus Therapy Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Oncolytic Virus Therapy Revenue Market Share, 2016-2027
Figure 30. Brazil Oncolytic Virus Therapy Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Oncolytic Virus Therapy Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Oncolytic Virus Therapy Revenue Market Share, 2016-2027
Figure 33. Turkey Oncolytic Virus Therapy Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Oncolytic Virus Therapy Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Oncolytic Virus Therapy Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Oncolytic Virus Therapy Revenue, (US$, Mn), 2016-2027
Figure 37. Amgen Oncolytic Virus Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Oncolytics Biotech Oncolytic Virus Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Viralytics Oncolytic Virus Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Transgene SA Oncolytic Virus Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Oncolys BioPharma Oncolytic Virus Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Targovax Oncolytic Virus Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. PsiOxus Therapeutics Oncolytic Virus Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. SillaJen Biotherapeutics Oncolytic Virus Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Sorrento Therapeutics Oncolytic Virus Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Lokon Pharma Oncolytic Virus Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Genelux Corporation Oncolytic Virus Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Vyriad Oncolytic Virus Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. TILT Biotherapeutics Oncolytic Virus Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)